The cost of uninformed medical consent runs into billions, says Mandi Smallhorne.
Athens' relations with the EU was an accident waiting to happen, says Leopold Scholtz.
Nene's budget may be a touch too conservative, says Jaco Leuvennink.
The Bidvest Group has "no aspiration" to buy all of Adcock Ingram, says its chief executive as the share price of its target traded above its offer price.
Leading health insurer Discovery is planning a rights issue to raise as much as R5bn to finance expansion, sending its shares down nearly 4%.
Drugmaker Adcock Ingram has reported a rise in half-year headline earnings per share, a sign that a turnaround plan is gaining traction.
Bidvest Group has offered to buy shares it doesn't already own in drugmaker Adcock Ingram Holdings.
The World Health Organisation has called on developing countries to invest $1 per person per year to tackle 17 neglected tropical diseases to improve people's health.
Britain might reduce welfare benefits for people who refuse treatment for obesity or drug and alcohol problems, says Prime Minister David Cameron.
US regulators have approved a commercialised biotech apple, rejecting efforts by the organic industry and other GMO critics to block the new fruit.
A UK biotech company founded by a Nobel prize winner has raised what it says is a record $1m via crowdfunding to help launch a stem cell-based regenerative medicine.
Medical patients who depend on machines such as oxygen tanks have expressed concern that load shedding could result in a fatal tragedy.
A global fund should be created to speed development of new antibiotics to counter superbugs, says a review backed by the British government.
The commissioner of the US Food and Drug Administration, who has overseen initiatives ranging from tobacco control and food safety, is stepping down.
What you need to keep your family going in a worst-case scenario.
Mentorship is the cornerstone to building a successful career as an entrepreneur.
Tax relief for small businesses and start-ups is a positive move, say experts.
High net worth individuals are in for a shock from the National Budget, expert says.
Mandi Smallhorne says President Zuma should've been honest about Sona chaos.
An entrepreneur found out the hard way that banks are not the only ones with money.
First learn about business before taking the entrepreneurial leap, says an expert.
Let us focus on job creation instead of bashing unions, says Mandi Smallhorne.
AstraZeneca has agreed to buy Actavis' branded respiratory drug business in the
United States and Canada for an initial $600m.
GlaxoSmithKline is expecting to start to regain market share in respiratory medicine after weak demand for lung drug Advair again hurt fourth-quarter sales.
The Square Kilometre Array project will lead to new innovations in manufacturing and construction and transform the SA economy, according to deputy president Cyril Ramaphosa.
Is highway robbery
Is a good boost for SA’s tax coffers
Doesn’t affect me
Previous results ·
Suggest a vote
Get your financial questions answered.
News delivered really simply.
Easy-to-use personal finance tools.
You choose what you want.
Your opinion on you, me and everyone.
Lost? Confused? Problems? Let us help you.